
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
Simon Erridge, Jess Kerr‐Gaffney, Carl Holvey, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 18
Simon Erridge, Jess Kerr‐Gaffney, Carl Holvey, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 18
Showing 18 citing articles:
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry
Fabian Olsson, Simon Erridge, James Tait, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 3, pp. 257-266
Open Access | Times Cited: 30
Fabian Olsson, Simon Erridge, James Tait, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 3, pp. 257-266
Open Access | Times Cited: 30
Virtual Care and Medical Cannabis Access: A Geospatial Study of Telehealth’s Role in Reducing Socioeconomic Disparities
Mitchell L. Doucette, Mark Kasabuski, Dipak Hemraj, et al.
Telemedicine Journal and e-Health (2025)
Closed Access
Mitchell L. Doucette, Mark Kasabuski, Dipak Hemraj, et al.
Telemedicine Journal and e-Health (2025)
Closed Access
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
Matthew Murphy, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 44, Iss. 1, pp. 129-142
Open Access | Times Cited: 9
Matthew Murphy, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 44, Iss. 1, pp. 129-142
Open Access | Times Cited: 9
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
Pim Ittiphakorn, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 596-606
Open Access | Times Cited: 7
Pim Ittiphakorn, Simon Erridge, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 596-606
Open Access | Times Cited: 7
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Adam Y. Li, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 6, pp. 350-360
Open Access | Times Cited: 2
Adam Y. Li, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 6, pp. 350-360
Open Access | Times Cited: 2
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
Simon Erridge, Ophilia Leung, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 616-632
Open Access | Times Cited: 3
Simon Erridge, Ophilia Leung, Carl Holvey, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 616-632
Open Access | Times Cited: 3
An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Factors for Implementing Medical Cannabis Cultivation in Brazil
Danielle L. de Oliveira, Ana Cláudia F. Amaral, Aline de Souza Ramos
The Natural Products Journal (2024) Vol. 15, Iss. 2
Closed Access
Danielle L. de Oliveira, Ana Cláudia F. Amaral, Aline de Souza Ramos
The Natural Products Journal (2024) Vol. 15, Iss. 2
Closed Access
Clinical outcome analysis of patients with multiple sclerosis – Analysis from the UK Medical Cannabis Registry
Matthew Murphy, Varinder Kaur, Hanh Lan Bui, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105665-105665
Open Access
Matthew Murphy, Varinder Kaur, Hanh Lan Bui, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105665-105665
Open Access
Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
BMJ Open (2024) Vol. 14, Iss. 7, pp. e085166-e085166
Open Access
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
BMJ Open (2024) Vol. 14, Iss. 7, pp. e085166-e085166
Open Access
O uso do cannabis no transtorno do espectro autista
Marcelo José da Silva de Magalhães, Fabricia Emanuelle Marques Rodrigues
Bionorte (2024) Vol. 13, Iss. 1, pp. 511-526
Open Access
Marcelo José da Silva de Magalhães, Fabricia Emanuelle Marques Rodrigues
Bionorte (2024) Vol. 13, Iss. 1, pp. 511-526
Open Access
A EFICÁCIA DO TRATAMENTO COM CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: UMA REVISÃO NARRATIVA DA LITERATURA
Ana Angélica Ferreira Bento Cardoso Leão, M. Gomes, Douglas Roberto Guimarães Silva
Revista Contemporânea (2024) Vol. 4, Iss. 10, pp. e6249-e6249
Open Access
Ana Angélica Ferreira Bento Cardoso Leão, M. Gomes, Douglas Roberto Guimarães Silva
Revista Contemporânea (2024) Vol. 4, Iss. 10, pp. e6249-e6249
Open Access
Factor Structure of Autism Symptoms in 5-6-Year-Old Children: Age Perspective
Andrey Nasledov, Liubov Tkacheva, Sergey Miroshnikov
OBM Neurobiology (2024) Vol. 08, Iss. 04, pp. 1-35
Open Access
Andrey Nasledov, Liubov Tkacheva, Sergey Miroshnikov
OBM Neurobiology (2024) Vol. 08, Iss. 04, pp. 1-35
Open Access
Absconding among admitted patients with bipolar affective disorder diagnosis in Uganda
Joan Abaatyo, Alain Favina, Mark Mohan Kaggwa
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Joan Abaatyo, Alain Favina, Mark Mohan Kaggwa
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
O USO DE CANNABIS MEDICINAL NO TRANSTORNO DO ESPECTRO AUTISTA: UMA NOVA TERAPÊUTICA VIÁVEL?
Larissa Ciarlini Varandas Sales, Guilherme Alvez Ferreira da Cruz, Tatiana Paschoalette Rodrigues Bachur
Revista Intertox de Toxicologia Risco Ambiental e Sociedade (2023) Vol. 16, Iss. 1, pp. 48-62
Open Access
Larissa Ciarlini Varandas Sales, Guilherme Alvez Ferreira da Cruz, Tatiana Paschoalette Rodrigues Bachur
Revista Intertox de Toxicologia Risco Ambiental e Sociedade (2023) Vol. 16, Iss. 1, pp. 48-62
Open Access
Letter to the editor: reflections on the future of medical cannabis research for depression
Simon Erridge, Sajed Mangoo, Mikael H. Sodergren
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 5, pp. 481-482
Open Access
Simon Erridge, Sajed Mangoo, Mikael H. Sodergren
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 5, pp. 481-482
Open Access